GENYO at ESGCT 2026
Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website
GENYO brings 4 presentations to ESGCT 2026 in Hamburg. Its work centres on CAR T cell design, including armoured cells that release IL-18 and how receptor density changes performance against HER2-positive tumours. A second strand builds CRISPR-based detection of single-letter DNA changes for clinical diagnosis.
| Organization | ESGCT 2026 Attendance |
|---|---|
GENYO Granada, Spain | |
Genomics and oncology research centre run jointly by Pfizer, the University of Granada and the Andalusian regional government. | Poster Wed Oct 28 1:30pm–3:30pm A Dual-Guide CRISPR-Cas13 platform for high-specificity single nucleotide variant detection in clinical diagnostics Poster Wed Oct 28 1:30pm–3:30pm A Multi-Tool Bioinformatic Pipeline for Consensus-Based Immunogenicity Risk Assessment in nanoCAR-T Cell Constructs. Poster Wed Oct 28 1:30pm–3:30pm Inducible IL-18 armored CAR-T cells demonstrate enhanced efficacy in vitro and in vivo but reveal donor-dependent variability in macrophage spheroid models Poster Thu Oct 29 2:00pm–4:00pm Reduced CAR density limits functional robustness in HER2+ solid tumors by sensitizing to antigen density and soluble antigen Chair Fri Oct 30 9:00am–10:30am SESSION 11c: Disease models Clinical trials and translation |
Instantly find 20 buyers from GENYO
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction